Skip to content

Vistagen Therapeutics, Inc.

VTGN· NasdaqCore metricsCIK 1411685

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -5.85%
Market cap
$8.17M
46.19M shares
Filings
913
$138.00K
Q2 2027+161.1% FY26 yoy
-$10.74M
Q2 2027N/M FY26 yoy
-$10.94M
Q2 2027N/M FY26 yoy
-$25.81M
FY 2024derivedN/M FY24 yoy
-$0.24
Q2 2027N/M FY26 yoy
$10.89M
Q2 2027−54.1% FY26 yoy
$8.17M
—
3.4×
0.5×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$0.176995.60%$3.8481past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.27MFY 2026
$1.34M-$227.00K0FY 2011FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-03-31$1,269,000reported
FY 20252025-03-31$486,000reported
FY 20242024-03-31$1,064,000reported
FY 20232023-03-31$227,000reported
FY 20222022-03-31$1,109,000reported
FY 20212021-03-31$1,089,500reported
FY 20202020-03-31$0reported
FY 20182018-03-31$0reported
FY 20172017-03-31$1,250,000reported
FY 20162016-03-31$0reported
FY 20122013-03-31$200,400reported
FY 20112012-03-31$1,342,200reported

Pharmaceutical preparations

Vistagen Therapeutics, Inc. is the 209th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR